Quantinno Capital Management LP Buys 7,174 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Quantinno Capital Management LP boosted its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 18.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 46,337 shares of the medical instruments supplier's stock after buying an additional 7,174 shares during the period. Quantinno Capital Management LP owned approximately 0.19% of ICU Medical worth $8,444,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ICUI. SG Americas Securities LLC lifted its stake in shares of ICU Medical by 441.7% in the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after purchasing an additional 4,744 shares during the period. LMR Partners LLP acquired a new position in ICU Medical in the third quarter valued at about $3,884,000. Savant Capital LLC acquired a new position in ICU Medical in the second quarter valued at about $431,000. First Eagle Investment Management LLC bought a new position in ICU Medical during the second quarter worth about $3,479,000. Finally, MetLife Investment Management LLC grew its position in shares of ICU Medical by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier's stock worth $2,258,000 after buying an additional 6,981 shares during the period. 96.10% of the stock is owned by institutional investors.

ICU Medical Stock Up 0.1 %

ICUI traded up $0.09 during trading on Friday, hitting $155.74. The company had a trading volume of 163,595 shares, compared to its average volume of 272,339. The company has a market capitalization of $3.81 billion, a PE ratio of -33.98 and a beta of 0.62. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a one year low of $83.26 and a one year high of $196.26. The firm's 50-day moving average price is $173.16 and its 200 day moving average price is $148.54.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ICUI. Raymond James increased their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. Jefferies Financial Group initiated coverage on shares of ICU Medical in a report on Monday, October 14th. They issued a "hold" rating and a $183.00 target price on the stock. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. Finally, KeyCorp lifted their target price on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, ICU Medical currently has an average rating of "Moderate Buy" and a consensus price target of $173.00.

Insider Activity

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $162.91, for a total value of $1,954,920.00. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $17,039,245.63. The trade was a 10.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Christian B. Voigtlander sold 1,962 shares of the business's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. Insiders have sold a total of 40,364 shares of company stock worth $6,869,878 over the last three months. Corporate insiders own 6.70% of the company's stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.